A Canadian Open-Label Access Program to Evaluate Adalimumab When Added to Inadequate Therapy for the Treatment of Psoriasis
Clinical trial NCT00513370 · COMPLETED
Trial details
- NCT number
- NCT00513370
- Sponsor
- Abbott
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-09-01
- Primary completion
- 2008-09-01
- Enrollment
- 203
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.